次世代エネルギー産業・グリーン経済の国際リサーチ情報サイト

医薬品受託製造および開発の世界市場:サービス別、エンドユーザー別2025年予測

Pharmaceutical Contract Development and Manufacturing Market (Pharmaceutical, Biologics, Active Pharma ingredients, tablet, Parenteral, Oral Liquid, Semi-Solids), End User (Big Pharma, Small Pharma, Generic Pharma,CRO)-Global Forecast to 2025

出版元:MarketsandMarketsLinkIcon出版元について
発行年:2021年3月
定価 Single User License(1名様ライセンス)US$4,950(米国ドル)/Multi User License(5名様)$6,650 /Corporate User License $8,150
ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
ご請求は円換算(お見積り日TTSレート)となります。
納品形態:PDF by Email
当調査レポートは英文192ページになります。
商品コード:MAM2359

お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。



【レポート紹介】
医薬品受託製造および開発の世界市場規模は2020年の推計1007億ドルから、2025年に1461億ドルへと拡大する見通しです。
レポートは医薬品受託製造および開発の世界市場について2025年までの市場予測データ(金額US$)を掲載しています。また市場をさまざまな切り口で細分化し、そのセグメント市場ごとの市場予測を中心に構成されています。当レポートでの各種セグメント市場の区分は、サービス別市場、エンドユーザー別市場、および主要国地域別市場、などとなっています。また競合状況、主要企業情報(12社)、バリューチェーン分析、ファイブフォース分析などの分析情報も加味し、医薬品受託製造および開発市場の今後成長性および動向を詳細にレポートしています。

【レポート構成概要】
◆医薬品受託製造および開発の世界市場予測2018-2025年
・市場規模(US$)

◆サービス別、市場-2025年
医薬品製造サービス
・API製造サービス
・FDF製造サービス
-非経口/注射製剤製造サービス
-錠剤製造サービス
-カプセル製造サービス
-経口液体製剤製造サービス
-半固体製剤製造サービス
-その他

医薬品開発サービス

生物製剤製造サービス
・API製造サービス
・FDF製造サービス
※(市場規模US$)

◆エンドユーザー別、市場-2025年
・大手製薬企業
・中小製薬企業
・ジェネリック製薬企業
・その他
※(市場規模US$)

◆主要国地域別市場-2025年
欧州
・ドイツ、イタリア、フランス
・英国、スイス、スペイン
・その他欧州
北米
・米国、カナダ
アジア太平洋
・日本、中国、インド、韓国
・その他アジア太平洋
中南米
中東アフリカ
※地域別に全セグメント別(中東アフリカを除く)の細分化データ掲載、詳細は目次参照
※国別に全セグメント別の細分化データ掲載

◆市場分析
・市場ダイナミクス(ドライバー、機会、課題)
・バリューチェーン分析
・ファイブフォース分析
・COVID-19による医薬品受託製造および開発市場への影響
・市場シェア分析
・競合状況

◆医薬品受託製造および開発の主要企業プロフィール動向
・LONZA GROUP          
・THERMO FISHER SCIENTIFIC INC.     
・CATALENT   
・RECIPHARM AB         
・ABBVIE          
・SIEGFRIED HOLDING AG       
・EVONIK INDUSTRIES
・BOEHRINGER INGELHEIM    
・PIRAMAL PHARMA SOLUTIONS         
・SAMSUNG BIOLOGICS           
・WUXI APPTEC (WUXI STA)    
・富士フイルムヘルスケア株式会社

(その他企業)
・VETTER PHARMA INTERNATIONAL  
・FAMAR HEALTH CARE SERVICES       
・AENOVA GROUP       
・ALMAC GROUP          
・CAMBREX     
・CORDENPHARMA     
・BIOVECTRA  
・ALBANY MOLECULAR RESEARCH

(全192頁)



【レポート詳細目次、データ項目一覧は当ページ下を参照ください】

英文詳細目次(table of contents)

【原文詳細目次】

Pharmaceutical Contract Development and Manufacturing Market (Pharmaceutical, Biologics, Active Pharma ingredients, tablet, Parenteral, Oral Liquid, Semi-Solids), End User (Big Pharma, Small Pharma, Generic Pharma,CRO)-Global Forecast to 2025

Table of Contents

1.... INTRODUCTION

1.1             OBJECTIVES OF THE STUDY
1.2             MARKET DEFINITION
1.2.1              INCLUSIONS & EXCLUSIONS
1.3             MARKET SCOPE
1.3.1              MARKETS COVERED.. 26
1.3.2              YEARS CONSIDERED FOR THE STUDY
1.4             CURRENCY
1.5             LIMITATIONS
1.6             STAKEHOLDERS
1.7             SUMMARY OF CHANGES

2.... RESEARCH METHODOLOGY

2.1             RESEARCH APPROACH
2.1.1              SECONDARY DATA
2.1.2              PRIMARY DATA
・       FIGURE 1 BREAKDOWN OF PRIMARIES: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET
2.1.3              MARKET DATA ESTIMATION & TRIANGULATION
・       FIGURE 2.......................... DATA TRIANGULATION METHODOLOGY
2.2             MARKET ESTIMATION METHODOLOGY
2.2.1              MARKET SIZE ESTIMATION APPROACH
・       FIGURE 3......... COMPANY REVENUE ANALYSIS-BASED ESTIMATION
・       FIGURE 4.......... PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET SIZE (USD BILLION): FINAL MARKET SIZE
2.3             GROWTH RATE ASSUMPTIONS/GROWTH FORECAST
・       FIGURE 5....................... FINAL CAGR PROJECTIONS (2020−2025)
2.4             INSIGHTS FROM PRIMARIES
・       FIGURE 6............... MARKET VALIDATION FROM PRIMARY EXPERTS
2.5             RESEARCH ASSUMPTIONS

3.... EXECUTIVE SUMMARY

・       FIGURE 7.......... PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET SHARE, BY SERVICE, 2019
・       FIGURE 8.. BIOLOGICS MANUFACTURING SERVICES MARKET SHARE, BY TYPE, 2019
・       FIGURE 9.......... PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2020 VS. 2025 (USD BILLION)
・       FIGURE 10.... GEOGRAPHICAL SNAPSHOT OF THE PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET

4.... PREMIUM INSIGHTS

4.1             PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET OVERVIEW
・       FIGURE 11.... GROWING DEMAND FOR GENERICS IS ONE OF THE KEY FACTORS DRIVING MARKET GROWTH
4.2             EUROPE: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET
・       FIGURE 12........ PHARMACEUTICAL MANUFACTURING SERVICES TO COMMAND THE LARGEST SHARE OF THE EUROPEAN PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET
4.3             PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET,
BY END USER
・       FIGURE 13 SMALL & MEDIUM-SIZED PHARMACEUTICAL COMPANIES TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD.. 41
4.4             PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
・       FIGURE 14... DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES BETWEEN 2020 & 2025

5.... MARKET OVERVIEW

5.1             INTRODUCTION
5.2             MARKET DYNAMICS
・       FIGURE 15......... PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET: DRIVERS, OPPORTUNITIES, CHALLENGES, AND TRENDS
5.2.1              DRIVERS
5.2.1.1            PATENT EXPIRY AND INCREASING DEMAND FOR GENERIC DRUGS
5.2.1.2            INCREASING INVESTMENTS IN PHARMACEUTICAL R&D
・       FIGURE 16.... NUMBER OF PHARMA COMPANIES WITH ACTIVE DRUG PIPELINE PROJECTS (2010–2020)
・       FIGURE 17........................ GLOBAL R&D SPENDING (2016–2020)
5.2.1.3            INVESTMENTS IN ADVANCED MANUFACTURING TECHNOLOGIES BY CDMOS
5.2.2              OPPORTUNITIES
5.2.2.1            INCREASING DEMAND FOR BIOLOGICAL THERAPIES
5.2.2.2            GROWTH IN THE NUCLEAR MEDICINE SECTOR
5.2.2.3            GROWING DEMAND FOR CELL AND GENE THERAPIES
5.2.3              CHALLENGES
5.2.3.1            INTRODUCTION OF SERIALIZATION
5.2.4              TRENDS
5.2.4.1            EXPANSION IN EMERGING COUNTRIES
5.2.4.2            CDMO INDUSTRY CONSOLIDATION
・       TABLE 1................................................ LIST OF ACQUISITIONS
5.3             VALUE CHAIN ANALYSIS
・       FIGURE 18......... VALUE CHAIN ANALYSIS OF THE PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET

5.4             ECOSYSTEM MARKET MAP
・       FIGURE 19......... ECOSYSTEM OF THE PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET
5.5             SUPPLY CHAIN
5.6             IMPACT OF THE COVID-19 PANDEMIC ON THE GROWTH OF THE PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET
・       TABLE 2...... AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
5.6.1              IMPACT ON THE PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET
・       FIGURE 20. PRE-COVID VS. POST-COVID-19 SCENARIO, 2019–2021
5.7             REGULATORY ASSESSMENT
5.7.1              INTRODUCTION
5.8             PORTER’S FIVE FORCES ANALYSIS
5.8.1              THREAT OF NEW ENTRANTS
5.8.2              THREAT OF SUBSTITUTES
5.8.3              BARGAINING POWER OF SUPPLIERS
5.8.4              BARGAINING POWER OF BUYERS
5.8.5              DEGREE OF COMPETITION

6.... PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE

6.1             INTRODUCTION
・       TABLE 3............ PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2018–2025 (USD MILLION)
6.2             PHARMACEUTICAL MANUFACTURING SERVICES
・       TABLE 4 PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
・       TABLE 5 PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.2.1              PHARMACEUTICAL API MANUFACTURING SERVICES
6.2.1.1            NEED TO CUT COSTS AND ENSURE FOCUS ON CORE AREAS LEADS COMPANIES TO OUTSOURCE API MANUFACTURING
・       TABLE 6 PHARMACEUTICAL API MANUFACTURING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.2.2              PHARMACEUTICAL FDF MANUFACTURING SERVICES
・       TABLE 7.......... PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 8.......... PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.2.2.1            PARENTERAL/INJEC・       TABLE MANUFACTURING SERVICES
6.2.2.1.1            NEED FOR HIGH LEVELS OF EXPERTISE AND GROWING DRUG DEVELOPMENT ACTIVITIES ARE DRIVING THE DEMAND FOR CONTRACT MANUFACTURING
・       TABLE 9.... PARENTERAL/INJEC・       TABLE MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2018–2025 (USD MILLION)
6.2.2.2            ・       TABLET MANUFACTURING SERVICES
6.2.2.2.1            SHIFTING MANUFACTURING REQUIREMENTS AND THE NEED TO STREAMLINE PRODUCTION PROCESSES ARE DRIVING MARKET GROWTH
・       TABLE 10. ・       TABLET MANUFACTURING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.2.2.3            CAPSULE MANUFACTURING SERVICES
6.2.2.3.1            GROWTH IN DEMAND FOR CAPSULE FORMULATIONS HAS ENSURED GROWTH OPPORTUNITIES FOR SERVICE PROVIDERS
・       TABLE 11.......... CAPSULE MANUFACTURING SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
6.2.2.4            ORAL LIQUID MANUFACTURING SERVICES
6.2.2.4.1            COMPLEXITIES INVOLVED IN ORAL LIQUID MANUFACTURING HAVE PROMPTED COMPANIES TO OPT FOR OUTSOURCING
・       TABLE 12...... ORAL LIQUID MANUFACTURING SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
6.2.2.5            SEMI-SOLID MANUFACTURING SERVICES
6.2.2.5.1            DEMAND FOR SPECIFIC MANUFACTURING FACILITIES TO BOOST THE OUTSOURCING OF SEMI-SOLIDS
・       TABLE 13...... SEMI-SOLID MANUFACTURING SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
6.2.2.6            OTHER FORMULATIONS MANUFACTURING SERVICES
・       TABLE 14........ OTHER FORMULATIONS MANUFACTURING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.3             DRUG DEVELOPMENT SERVICES
6.3.1              DRUG SUBSTANCE COMPLEXITY AND HIGH COSTS HAVE SUPPORTED THE OUTSOURCING OF DRUG DEVELOPMENT
・       TABLE 15.... DRUG DEVELOPMENT SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
6.4             BIOLOGICS MANUFACTURING SERVICES
・       TABLE 16 BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 17........ BIOLOGICS MANUFACTURING SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
6.4.1              BIOLOGICS API MANUFACTURING SERVICES
6.4.1.1            MARKET FOR BIOLOGICS API MANUFACTURING IS STILL IN THE NASCENT PHASE
・       TABLE 18... BIOLOGICS API MANUFACTURING SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
6.4.2              BIOLOGICS FDF MANUFACTURING SERVICES
6.4.2.1            INCREASING R&D COSTS AND PROCESS COMPLEXITY HAVE PROMPTED THE SHIFT TOWARD CONTRACT MANUFACTURING
・       TABLE 19.. BIOLOGICS FDF MANUFACTURING SERVICES MARKET, BY COUNTRY,
2018–2025 (USD MILLION)

7.... PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER

7.1             INTRODUCTION
・       TABLE 20........... PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2018–2025 (USD MILLION)
7.2             BIG PHARMACEUTICAL COMPANIES
7.2.1              EMERGENCE OF NEW MEDICINES AND THERAPIES TO CONTRIBUTE TO THE GROWTH OF THIS MARKET
・       TABLE 21........... PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET FOR BIG PHARMACEUTICAL COMPANIES, BY COUNTRY,
2018–2025 (USD MILLION)
7.3             SMALL & MEDIUM-SIZED PHARMACEUTICAL COMPANIES
7.3.1              GROWING DEVELOPMENT OF BIOLOGIC DRUGS AND HIGH PRICING PRESSURE TO BOOST MARKET GROWTH
・       TABLE 22........... PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET FOR SMALL & MEDIUM-SIZED PHARMACEUTICAL COMPANIES,
BY COUNTRY, 2018–2025 (USD MILLION)
7.4             GENERIC PHARMACEUTICAL COMPANIES
7.4.1              GROWING DEMAND FOR GENERICS TO SUPPORT MARKET GROWTH
・       TABLE 23........... PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET FOR GENERIC PHARMACEUTICAL COMPANIES, BY COUNTRY,
2018–2025 (USD MILLION)
7.5             OTHER END USERS
・       TABLE 24........... PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET FOR OTHER END USERS, BY COUNTRY, 2018–2025 (USD MILLION)

8.... PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY REGION

8.1             INTRODUCTION
・       FIGURE 21......... PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET: GEOGRAPHICAL SNAPSHOT
・       TABLE 25........... PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY REGION, 2018–2025 (USD MILLION). 88
8.2             EUROPE
・       FIGURE 22... EUROPE: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET SNAPSHOT
・       TABLE 26..... EUROPE: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
・       TABLE 27..... EUROPE: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2018–2025 (USD MILLION)
・       TABLE 28.. EUROPE: PHARMACEUTICAL MANUFACTURING SERVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 29.......... EUROPE: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 30 EUROPE: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
・       TABLE 31..... EUROPE: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2018–2025 (USD MILLION)
8.2.1              GERMANY
8.2.1.1            HIGH HEALTHCARE EXPENDITURE AND INCREASED PHARMACEUTICAL PRODUCTION TO SUPPORT MARKET GROWTH
・       TABLE 32.. GERMANY: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2018–2025 (USD MILLION)
・       TABLE 33 GERMANY: PHARMACEUTICAL MANUFACTURING SERVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 34........ GERMANY: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 35......... GERMANY: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 36.. GERMANY: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2018–2025 (USD MILLION)
8.2.2              ITALY
8.2.2.1            INCREASING FOCUS ON CLINICAL RESEARCH AND THE GROWING POPULARITY OF BRANDED DRUGS ARE DRIVING THE DEMAND FOR CONTRACT DEVELOPMENT AND MANUFACTURING
・       TABLE 37.. ITALY: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2018–2025 (USD MILLION)
・       TABLE 38...... ITALY: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 39 ITALY: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 40 ITALY: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
・       TABLE 41.. ITALY: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2018–2025 (USD MILLION)
8.2.3              FRANCE
8.2.3.1            PRESENCE OF LEADING PHARMACEUTICAL COMPANIES TO SUPPORT MARKET GROWTH IN FRANCE
・       TABLE 42..... FRANCE: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2018–2025 (USD MILLION)
・       TABLE 43.. FRANCE: PHARMACEUTICAL MANUFACTURING SERVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 44.......... FRANCE: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 45 FRANCE: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
・       TABLE 46..... FRANCE: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2018–2025 (USD MILLION)
8.2.4              UK
8.2.4.1            GROWTH IN THE GENERICS MARKET AND THE RISING COST OF MANUFACTURING PARENTERAL FORMULATIONS ARE DRIVING MARKET GROWTH
・       TABLE 47..... UK: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2018–2025 (USD MILLION)
・       TABLE 48......... UK: PHARMACEUTICAL MANUFACTURING SERVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 49... UK: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 50.. UK: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
・       TABLE 51..... UK: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2018–2025 (USD MILLION)
8.2.5              SWITZERLAND
8.2.5.1            LARGE VOLUME OF PHARMACEUTICAL PRODUCTION AND GROWING SCOPE FOR GENERICS TO PROVIDE GROWTH OPPORTUNITIES
・       TABLE 52................. SWITZERLAND: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2018–2025 (USD MILLION)
・       TABLE 53........ SWITZERLAND: PHARMACEUTICAL MANUFACTURING SERVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 54.. SWITZERLAND: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 55.... SWITZERLAND: BIOLOGICS MANUFACTURING SERVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 56................. SWITZERLAND: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2018–2025 (USD MILLION)
8.2.6              SPAIN
8.2.6.1            INCREASE IN BIOLOGICS PRODUCTION TO SUPPORT MARKET GROWTH
・       TABLE 57. SPAIN: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2018–2025 (USD MILLION)
・       TABLE 58..... SPAIN: PHARMACEUTICAL MANUFACTURING SERVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 59 SPAIN: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 60.. SPAIN: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
・       TABLE 61. SPAIN: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2018–2025 (USD MILLION)
8.2.7              REST OF EUROPE
・       TABLE 62.... ROE: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2018–2025 (USD MILLION)
・       TABLE 63....... ROE: PHARMACEUTICAL MANUFACTURING SERVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 64.. ROE: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 65. ROE: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
・       TABLE 66.... ROE: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2018–2025 (USD MILLION)
8.3             NORTH AMERICA
・       TABLE 67.............. NORTH AMERICA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
・       TABLE 68.............. NORTH AMERICA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2018–2025 (USD MILLION)
・       TABLE 69..... NORTH AMERICA: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 70 NORTH AMERICA: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 71 NORTH AMERICA: BIOLOGICS MANUFACTURING SERVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 72.............. NORTH AMERICA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2018–2025 (USD MILLION)
8.3.1              US
8.3.1.1            THE US DOMINATES THE NORTH AMERICAN PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET
・       TABLE 73..... US: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2018–2025 (USD MILLION)
・       TABLE 74......... US: PHARMACEUTICAL MANUFACTURING SERVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 75... US: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 76.. US: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
・       TABLE 77..... US: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2018–2025 (USD MILLION)
8.3.2              CANADA
8.3.2.1            GROWTH OF THE EMERGING MARKETS AND SLOWDOWN IN NEW PRODUCT APPROVALS WILL HAMPER THE MARKET GROWTH
・       TABLE 78.... CANADA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2018–2025 (USD MILLION)
・       TABLE 79.. CANADA: PHARMACEUTICAL MANUFACTURING SERVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 80.......... CANADA: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 81 CANADA: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
・       TABLE 82.... CANADA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2018–2025 (USD MILLION)
8.4             ASIA PACIFIC
・       FIGURE 23................ ASIA PACIFIC: PHARMACEUTICAL CONTRACT DEVELOPMENT
AND MANUFACTURING MARKET SNAPSHOT
・       TABLE 83.................. ASIA PACIFIC: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
・       TABLE 84.................. ASIA PACIFIC: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2018–2025 (USD MILLION)
・       TABLE 85......... ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING SERVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 86.... ASIA PACIFIC: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 87..... ASIA PACIFIC: BIOLOGICS MANUFACTURING SERVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 88.................. ASIA PACIFIC: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2018–2025 (USD MILLION)
8.4.1              CHINA
8.4.1.1            FAVORABLE GOVERNMENT REGULATIONS ARE FUELING MARKET GROWTH IN CHINA
・       TABLE 89. CHINA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2018–2025 (USD MILLION)
・       TABLE 90.... CHINA: PHARMACEUTICAL MANUFACTURING SERVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 91 CHINA: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 92.. CHINA: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
・       TABLE 93. CHINA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2018–2025 (USD MILLION)
8.4.2              INDIA
8.4.2.1            LOW MANUFACTURING COSTS AND A SKILLED WORKFORCE ARE FACTORS ATTRACTING OUTSOURCING AND INVESTMENT TO INDIA
・       TABLE 94.. INDIA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2018–2025 (USD MILLION)
・       TABLE 95..... INDIA: PHARMACEUTICAL MANUFACTURING SERVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 96 INDIA: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 97... INDIA: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
・       TABLE 98.. INDIA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2018–2025 (USD MILLION)
8.4.3              SOUTH KOREA
8.4.3.1            GOVERNMENT INVESTMENTS ARE A KEY CONTRIBUTOR TO MARKET GROWTH IN SOUTH KOREA
・       TABLE 99................. SOUTH KOREA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2018–2025 (USD MILLION)
・       TABLE 100...... SOUTH KOREA: PHARMACEUTICAL MANUFACTURING SERVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 101.. SOUTH KOREA: BIOLOGICS MANUFACTURING SERVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION)
8.4.4              JAPAN
8.4.4.1            GROWING GENERICS DEMAND AND GOVERNMENT INITIATIVES TO DRIVE THE DEMAND FOR CONTRACT MANUFACTURING OF DRUGS
・       TABLE 102 JAPAN: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2018–2025 (USD MILLION)
・       TABLE 103... JAPAN: PHARMACEUTICAL MANUFACTURING SERVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 104........... JAPAN: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 105 JAPAN: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
・       TABLE 106 JAPAN: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2018–2025 (USD MILLION)
8.4.5              REST OF ASIA PACIFIC
・       TABLE 107... ROAPAC: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2018–2025 (USD MILLION)
・       TABLE 108 ROAPAC: PHARMACEUTICAL MANUFACTURING SERVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 109........ ROAPAC: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 110......... ROAPAC: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE,
2018–2025 (USD MILLION)
・       TABLE 111... ROAPAC: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2018–2025 (USD MILLION)
8.5             LATIN AMERICA
8.5.1              FAVORABLE COST STRUCTURE AND GOVERNMENT INVESTMENTS TO DRIVE PHARMACEUTICAL PRODUCTION IN LATAM... 127
・       TABLE 112.............. LATIN AMERICA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2018–2025 (USD MILLION)
・       TABLE 113.... LATIN AMERICA: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 114 LATIN AMERICA: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 115 LATIN AMERICA: BIOLOGICS MANUFACTURING SERVICES MARKET,
BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 116.............. LATIN AMERICA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2018–2025 (USD MILLION)
8.6             MIDDLE EAST & AFRICA

8.6.1              GOVERNMENT SUPPORT TO BOOST LOCAL PRODUCTION IS EXPECTED TO OFFER GROWTH OPPORTUNITIES FOR CONTRACT MANUFACTURERS IN THE REGION
・       TABLE 117... MIDDLE EAST & AFRICA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2018–2025 (USD MILLION)
・       TABLE 118.................. MIDDLE EAST & AFRICA: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 119.... MIDDLE EAST & AFRICA: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)

9.... COMPETITIVE LANDSCAPE

9.1             OVERVIEW
9.2             REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
9.3             MARKET SHARE ANALYSIS
・       FIGURE 25......... PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET RANK, BY KEY PLAYER, 2019
・       TABLE 120......... PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET: DEGREE OF COMPETITION
9.4             COMPETITIVE LEADERSHIP MAPPING
9.4.1              STARS
9.4.2              EMERGING LEADERS.. 136
9.4.3              PERVASIVE PLAYERS.. 136
9.4.4              PARTICIPANTS
・       FIGURE 26......... PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET: COMPANY EVALUATION QUADRANT (2019). 137
9.5             PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET: START-UP/SME EVALUATION MATRIX, 2019
9.5.1              PROGRESSIVE COMPANIES
9.5.2              STARTING BLOCKS
9.5.3              RESPONSIVE COMPANIES
9.5.4              DYNAMIC COMPANIES
・       FIGURE 27......... PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET: STARTUP/SME EVALUATION MATRIX, 2019
9.6             COMPANY SERVICE FOOTPRINT
・       TABLE 121........ SERVICE PORTFOLIO ANALYSIS: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET
9.7             COMPANY GEOGRAPHIC FOOTPRINT OF MAJOR PLAYERS IN THE PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET
・       TABLE 122............ GEOGRAPHIC REVENUE MIX: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET (2019)
9.8             COMPETITIVE SCENARIO
・       TABLE 123......... PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET: SERVICE LAUNCHES, MAY 2019–OCTOBER 2020
・       TABLE 124......... PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET: DEALS, MARCH 2019–JANUARY 2021
・       TABLE 125......... PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET: OTHERS, MAY 2019–NOVEMBER 2020

10.. COMPANY PROFILES

(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, SWOT ANALYSIS, MNM VIEW)*
10.1          MAJOR PLAYERS
10.1.1            LONZA GROUP
・       TABLE 126.......................... LONZA GROUP: BUSINESS OVERVIEW
・       FIGURE 28................ LONZA GROUP: COMPANY SNAPSHOT (2020)
・       TABLE 127............................ LONZA GROUP: SERVICES OFFERED
10.1.2            THERMO FISHER SCIENTIFIC INC.
・       TABLE 128........ THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
・       FIGURE 29........ THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2019)
・       TABLE 129.......... THERMO FISHER SCIENTIFIC: SERVICES OFFERED
10.1.3            CATALENT
・       TABLE 130................................ CATALENT: BUSINESS OVERVIEW
・       FIGURE 30..................... CATALENT: COMPANY SNAPSHOT (2020)
・       TABLE 131.................................. CATALENT: SERVICES OFFERED
10.1.4            RECIPHARM AB
・       TABLE 132........................ RECIPHARM AB: BUSINESS OVERVIEW
・       FIGURE 31.............. RECIPHARM AB: COMPANY SNAPSHOT (2019)
・       TABLE 133.......................... RECIPHARM AB: SERVICES OFFERED
10.1.5            ABBVIE
・       TABLE 134................................... ABBVIE: BUSINESS OVERVIEW
・       FIGURE 32......................... ABBVIE: COMPANY SNAPSHOT (2019)
・       TABLE 135..................................... ABBVIE: SERVICES OFFERED
10.1.6            SIEGFRIED HOLDING AG
・       TABLE 136.............. SIEGFRIED HOLDING AG: BUSINESS OVERVIEW
・       FIGURE 33... SIEGFRIED HOLDING AG: COMPANY SNAPSHOT (2019)
・       TABLE 137................ SIEGFRIED HOLDING AG: SERVICES OFFERED
10.1.7            EVONIK INDUSTRIES.. 167
・       TABLE 138.................. EVONIK INDUSTRIES: BUSINESS OVERVIEW
・       FIGURE 34........ EVONIK INDUSTRIES: COMPANY SNAPSHOT (2019)
・       TABLE 139.................... EVONIK INDUSTRIES: SERVICES OFFERED
10.1.8            BOEHRINGER INGELHEIM
・       TABLE 140............ BOEHRINGER INGELHEIM: BUSINESS OVERVIEW
・       FIGURE 35.. BOEHRINGER INGELHEIM: COMPANY SNAPSHOT (2019)
・       TABLE 141.............. BOEHRINGER INGELHEIM: SERVICES OFFERED
10.1.9            PIRAMAL PHARMA SOLUTIONS
・       TABLE 142..... PIRAMAL PHARMA SOLUTIONS: BUSINESS OVERVIEW
・       FIGURE 36.... PIRAMAL PHARMA SOLUTIONS: COMPANY SNAPSHOT (2019)
・       TABLE 143....... PIRAMAL PHARMA SOLUTIONS: SERVICES OFFERED
10.1.10         SAMSUNG BIOLOGICS
・       TABLE 144................ SAMSUNG BIOLOGICS: BUSINESS OVERVIEW
・       FIGURE 37..... SAMSUNG BIOLOGICS: COMPANY SNAPSHOT (2019)
・       TABLE 145.................. SAMSUNG BIOLOGICS: SERVICES OFFERED
10.1.11         WUXI APPTEC (WUXI STA)
・       TABLE 146........................... WUXI APPTEC: BUSINESS OVERVIEW
・       FIGURE 38................. WUXI APPTEC: COMPANY SNAPSHOT (2019)
・       TABLE 147............................. WUXI APPTEC: SERVICES OFFERED
10.1.12         FUJIFILM HEALTHCARE
・       TABLE 148............... FUJIFILM HEALTHCARE: BUSINESS OVERVIEW
・       FIGURE 39..... FUJIFILM HEALTHCARE: COMPANY SNAPSHOT (2019)
・       TABLE 149................. FUJIFILM HEALTHCARE: SERVICES OFFERED
10.2          OTHER PLAYERS
10.2.1            VETTER PHARMA INTERNATIONAL
・       TABLE 150.. VETTER PHARMA INTERNATIONAL: BUSINESS OVERVIEW
・       TABLE 151.... VETTER PHARMA INTERNATIONAL: SERVICES OFFERED
10.2.2            FAMAR HEALTH CARE SERVICES
・       TABLE 152... FAMAR HEALTH CARE SERVICES: BUSINESS OVERVIEW
・       TABLE 153..... FAMAR HEALTH CARE SERVICES: SERVICES OFFERED
10.2.3            AENOVA GROUP
・       TABLE 154........................ AENOVA GROUP: BUSINESS OVERVIEW
・       TABLE 155.......................... AENOVA GROUP: SERVICES OFFERED
10.2.4            ALMAC GROUP
10.2.5            CAMBREX
10.2.6            CORDENPHARMA
10.2.7            BIOVECTRA
10.2.8            ALBANY MOLECULAR RESEARCH
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, SWOT ANALYSIS, MNM VIEW MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
11.. APPENDIX


 



掲載企業リスト

プレスリリース

プレスリリース

Memo.png当レポートのプレスリリースは発行されておりません。

資料検索

お探しの資料・レポートをキーワードで検索ください。

当サイト内の検索結果が表示されます。調査レポートは英文目次を掲載しているため、英語検索も有効です。
(ブラウザのスクリプトを有効にしないとサーチエンジンが表示されません)

お問い合わせ

2714110_0.jpg
レポートをお探しいたします。
当サイトに掲載されているレポート以外にも幅広くご提案可能です。レポートの内容に関するご質問、ご確認にも回答いたします。お気軽にお問い合わせください。